Doctoral Students - Ph.D. candidate in Stuttgart bei Robert Bosch Centrum für Tumorerkrankungen

The group „Apoptosis Regulation and Targeted Therapy" (PD Dr. Frank Essmann), at the Robert Bosch Center for Tumor Diseases (RBCT) announces an opportunity for a passionate and dedicated young scientist (f/m/d) to join our dynamic team as a PhD student. The project investigates the resistance mechanisms to targeted therapy in non-small cell lung cancer, a critical area of cancer research.

Our group is an integral part of the Robert Bosch Center for Tumor Diseases, a cutting-edge institution strategically located adjacent to the Robert Bosch Hospital and the Institute for Clinical Pharmacology in Stuttgart, Germany. Situated on the Bosch Health Campus, the these Institutes together with the Robert Bosch Hospital form a nexus of international research and clinical expertise. Our collaborative environment is enhanced by our affiliation with the Comprehensive Cancer Center (CCC) Stuttgart/Tübingen and the National Centre for Tumor Diseases (NCT). At the Bosch Health Campus, teams of global researchers and clinicians employ advanced technologies to translate molecular discoveries into tangible clinical treatments.

The Bosch Health Campus fosters a vibrant, team-oriented international atmosphere. Research groups here delve into a variety of compelling topics including the (epigenetic) regulation of transcription, immunology/inflammation, targeted therapy, and cell death regulation. This PhD project, offering independent funding, will be co-supervised by PD Dr. Frank Essmann of the RBCT and Prof. Dr. Hans-Georg Kopp from the Department of Thoracic Oncology at the Robert Bosch Hospital.

We are seeking candidates who demonstrate:

• A profound interest in life sciences, specifically in the molecular mechanisms of signal transduction and oncology.
• A Master of Science (M.Sc.) degree or equivalent in molecular medicine, biochemistry, chemistry, biology, or related fields.
• Prior experience in life sciences, molecular biology, or protein biochemistry.
• Fluency in English is a requirement, while proficiency in German is advantageous but not essential.

To apply, please submit a comprehensive CV with references and a concise, one-page letter of motivation as a single PDF file. Inclusion of a letter of recommendation is encouraged. We also value prior publications (e.g., poster presentations, talks, manuscripts) and international experience, although these are not mandatory.

Applications will be processed on a rolling basis, with interviews conducted online or in-person at the earliest convenience. The Robert Bosch Center for Tumor Diseases is committed to diversity and encourages applications from all qualified individuals, regardless of race, gender, or disability.

• Access to state of the art core infrastructure (next generation sequencing, single cell analyses, histological analysis, S2 laboratory, IT-infrastructure, bioinformatics, translational murine model facility, live cell imaging, multispectral imaging of histological samples, etc.).
• Modern, fully equipped laboratory space.

For information and publications from Frank Essmann please see:

https://orcid.org/0000-0003-4369-8456
https://www.ncbi.nlm.nih.gov/myncbi/1lEkbtyu5z9Q6/bibliography/public/

Contact:
PD Dr. rer. nat. Frank Essmann
rbct-sekretariat@bosch-health-campus.com

Sind Sie bereit für eine neue Herausforderung? Dann bewerben Sie sich jetzt über unser Online-Karriereportal.

Die angegebenen Arbeitgeberleistungen können je nach Position und Anstellungsverhältnis variieren.

Bitte beachten Sie die geltenden Nachweispflichten aufgrund des Infektionsschutzgesetzes als Einstellungsvoraussetzung.

Wir schätzen die Einzigartigkeit und Unterschiedlichkeit unserer Mitarbeitenden und fördern ein Arbeitsumfeld, das unabhängig von Alter, Geschlecht, sexueller Identität, Behinderung, Herkunft oder Religion gleiche Chancen ermöglicht.

Mit Einreichung Ihrer Bewerbungsunterlagen stimmen Sie zu, dass Ihre Bewerberdaten in der Bewerbermanagementsoftware SmartRecruiters aufgenommen und verarbeitet werden. Hinweise zu unserem Datenschutz finden Sie hier: Datenschutz.